Weekly Vaccine Digest 03/15/2024
County of Los Angeles, California sent this bulletin at 03/15/2024 03:21 PM PDT|
Weekly Vaccine Digest 03/15/2024 Los Angeles County Department of Public Health |
Dear Colleagues and Partners!
Below are the LACDPH weekly vaccine administration and order updates, upcoming webinars, and newsworthy events. Attached you will find a pdf version of this document. To view past CDPH recordings, slides and other important information on the VFC, VFA, BAP and LHD 317 programs please visit https://eziz.org/. If you received this email and would like to be added to our listserv, please contact our COVID-19 Provider Vaccine Call Center at covidvaccinereq@ph.lacounty.gov
|
Table of Contents
|
Measles Update
Measles is a very contagious disease caused by a virus. About 9 out of 10 people who are not protected will become infected following exposure to the measles virus. It spreads through the air when a person with measles coughs or sneezes. Measles starts with a cough, runny nose, red eyes, and fever. Then a rash of red spots breaks out.
Share messages reminding Californians to make sure they and their children are up to date on the MMR (measles-mumps-rubella) vaccine and other recommended routine vaccines, including flu and COVID-19, especially before travel. Learn more about measles activity in California. Learn more about routine vaccines. Visit the Don’t Wait—Vaccinate! Communications Toolkit (updated).
Suggested Message: Protect Your Family from Measles this Spring Break
Measles cases have been confirmed in California and the U.S. in recent weeks. Cases have been linked to overseas travel, reflecting the global rise in measles cases. Share messages encouraging everyone to stay up to date with measles-mumps-rubella vaccinations (MMR), and other routine vaccines, especially if they plan to travel abroad for spring break.
Learn more:
- Learn more about measles activity in California.
- Learn more about routine vaccines.
- Visit the Don’t Wait—Vaccinate! Communications Toolkit.
- Visit Measles, Mumps, and Rubella (MMR) Vaccination: What Everyone Should Know (CDC)
- Read the CDPH measles health advisory.
- State Epidemiologist Dr. Erica Pan Discusses Preteen Vaccination
Check out the new CDPH video, featuring State Epidemiologist Dr. Erica Pan, reminding parents and caregivers about routine immunizations for preteens and teens, including ones for whooping cough, cancers caused by the human papillomavirus (HPV) , and meningitis.
Learn more about preteen vaccines.
Visit the CDPH Preteen Vaccine Week communications toolkit.
HPV Vaccine Schedule job aid can be found here.
Preteen Vaccination Week (PVW) campaign can be found here
Changes to Pfizer Diluent
- Pfizer has changed the diluent pack size associated with CDC orders of Pfizer COVID-19 Vaccine (2023-2024 Formula) for ages 6 months through 4 years of age [59267-4315-02; COVID-19(Pfizer);(6m-4y); MDV3;10-pk].
- Pfizer is now supplying diluent in a 25-pack.
- Previously vaccine orders for this presentation were supplied with diluent in a 10-pack.
- Please note: One vial of diluent is required to reconstitute one multidose vial of vaccine for individuals 6 months through 4 years of age.
- For questions about diluent received with Pfizer COVID-19 Vaccine (2023-2024 Formula) for ages 6 months through 4 years of age, please contact Pfizer customer service at: 1-800-666-7248, or mrnavaccines@pfizer.com.
New Presentation and National Drug Code (NDC) for Hiberix
- The prior presentation of Hiberix (NDC 58160-0818- 11, one vial of lyophilized antigen and one vial of diluent) is no longer available.
- It has been replaced with a new presentation of Hiberix (NDC 58160-0726-15, one vial of lyophilized antigen and one prefilled syringe of diluent) and has been made available for ordering through the VFC order form as of March 1, 2024.
- Please continue to use any remaining doses of the prior presentation of Hiberix before using the new presentation to ensure doses are not wasted.
COVID-19 Vaccine Update: All Adults 65+ Recommended to Get Additional COVID-19 Vaccine
CDC now recommends that all adults ages 65 years and older receive an additional updated 2023-2024 COVID19 vaccine dose to help protect against severe disease from COVID-19. For more information, see CDC’s press release. Persons ≥ 65 years of age should receive an additional dose of 2023-2024 COVID-19 vaccine, at least 4 months after previous updated (2023-2024) COVID-19 vaccine dose.
Guidance for Immunocompromised People:
Further additional doses may be administered, informed by the clinical judgement of a healthcare provider and personal preference and circumstances, at least 2 months after the last updated (2023–2024 Formula) COVID-19 vaccine dose.
Updated CDPH Timing Guide (COVID) can be found here and the Spanish version can be found here
COVID-19 Testing Updates
CDPH At-Home Testing Program: As of February 29, 2024, the CDPH At-Home Testing Program has come to an end and COVID-19 at-home tests are no longer available to request from CDPH.
Professional CLIA-waived tests: Professional tests available to facilities with their own CLIA-waiver and state facility license through June 30, 2024. Eligible facilities would be Skilled Nursing Facilites, Long-Term Care Facilities and Community Clinics.
BinaxNOW CLIA-waived tests have extended expiration dates through July 2024.
We have depleted our inventory of COVID/Flu A&B multiplex tests. Should these tests become available again, we will notify this group of their availability.
Order professional CLIA-waived tests here: https://labsupport.powerappsportals.us/ordercovidprofessionaluse/
UPCOMING WEBINARS
- Afternoon TEAch: Best Practices for Promoting Adolescent Vaccination on Tuesday, March 26, 2024, 12-1pm PT
-
CDPH Infection Prevention Webinar on Wednesday, March 27, 2024
- Webinar registration links for Webex can be found here.
-
California Immunization Coalition Annual Summit
- Location: The Safe Credit Union Convention Center in Sacramento, CA - June 5-6, 2024
- Registration Link
myCAvax Release 46 (March 15,2024)
Vaccine Inventory Management:
-
Updated Multi-line Returns and Waste Events Forms
- Providers enrolled in the Bridge Access Program (BAP) and the State General Fund (SGF) program can record BAP and SGF Returns and Waste Events for multiple products using the updated multi-line Returns and Waste Events forms.
-
Updated Multi-line Excursions Forms
- Providers enrolled in the BAP and SGF programs can record BAP and SGF Excursions for multiple products using the updated multi-line Excursions forms.
Excursions:
-
Removed Buttons from Excursion Records
- Providers enrolled in the Vaccines for Adults (VFA) or LHD 317 program can no longer view the ‘+ Follow,’ ‘New Note,’ ‘Clone,’ or ‘Change Owner’ buttons on an excursion record.
-
Removed ‘Batch Excursions’ Related List
- Providers enrolled in the VFA or LHD 317 program can no longer view the ‘Batch Excursions’ related list on Program Locations and Organization Accounts.
Provider Community Site:
-
Restricted Edit Access on Orders
- Providers enrolled in the VFA or LHD 317 program can update the ‘Order Lines’ section on an order only when it is in the ‘Draft’ or ‘Corrections Needed’ status.
-
Relabeled Column Name
- Providers enrolled in the VFA or LHD 317 program can view the ‘Batch Order Number’ column relabeled to ‘Order Number’ on the ‘Vaccines for Adults Orders’ or ‘LHD 317 Orders’ page.
-
Restricted View Access on Orders
- Providers enrolled in the VFA or LHD 317 program can view the ‘Current Shipping and Vaccine Administration Address,’ ‘Current Shipping Hours,’ and ‘Temporary Closure’ sections on an order only when it is in the ‘Draft’ or ‘Corrections Needed’ status.
-
Updated Footer on All Pages
- Providers can view an updated footer with the Provider Call Center and Help Desk contact information on all pages.
Vaccine Ordering:
-
‘Order size reason’ Field Made Mandatory
- Providers enrolled in the VFA or LHD 317 program must provide the ‘Order size reason’ for an order in the ‘Draft’ or ‘Corrections Needed’ status if the order size exceeds the recommended order size.
-
Order Inventory Reporting for Products Made Mandatory
- Providers enrolled in the VFA or LHD 317 program must report inventory for a product on the multi-line ordering form if the product is available for order inventory reporting.
-
Order Size Restrictions
- Providers enrolled in the VFA or LHD 317 program will not be able to place an order beyond the product’s ‘Order Maximum’ value.
myCAvax Educational Materials
Please visit EZIZ for program updates or use the Knowledge Center to access Job Aids.
You are welcome to share this information with myCAvax team members or business partners who may not have received it. If you have questions, please contact:
Provider Call Center – Phone: (833) 502-1245; Email: myCAvax.HD@cdph.ca.gov
Hours of Operation: Monday to Friday, 8:00 AM to 5:00 PM (PT)
LACDPH & CDPH Provider Office Hours Link
LA County Department of Public Health Provider Immunization Office Hours Information
-
Every other Wednesday from 9am-10am – Next session on March 27, 2024
- NOTE: Effective 2/01/23 the Office Hours will be held on a biweekly basis
This has been meeting amended to discuss COVID, Mpox, Flu, RSV and Measles vaccines. The meeting link will remain the same.
- MS Teams meeting link below; please create a recurring calendar invite with this link.
- To request meeting slides or be added to our Office Hours listserv, please email covidvaccinereq@ph.lacounty.gov
Microsoft Teams meeting
Join on your computer or mobile app
Click here to join the meeting
Or call in (audio only)
+1 323-776-6996,,350547595# United States, Los Angeles
Phone Conference ID: 350 547 595#
California Department of Public Health Provider Office Hours Registration Link
- NOTE: CDPH Provider Office Hours will be moving to a biweekly cadence. The next Provider Office Hours will be held next week Friday March 22, 2024 from 9am-10:30am.
- Complete one-time registration here.
- Meeting recordings and slides can be found here.
Providers should add staff names to the Provider Listserv to receive weekly emails and updates. To be added, please email blanca.corona@cdph.ca.gov